Skip to content
GLP-1 Scorecard
Menu
Site position #282

Medro

Published by GLP-1 ScorecardUpdated

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and licensed pharmacy partners in all 50 states.

Visit MedroWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
$299/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

Weigh Medro against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value50/100
Dose & formulation77/100
Clinical oversight71/100
Labs & monitoring52/100
Fulfillment92/100
Contract terms33/100

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

What to consider

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Bottom line — Grade C

Best for: Shoppers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.

Site position #282 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Visit Medro

Closest here

The rankings grading nearest Medro — the realistic shortlist.

Invyncible#281

Invyncible pairs a named pharmacy network with refills requested by the patient; compare the exact formulation and supply length before treating a vial price as a monthly cost.

Oria Meds#283

Oria Meds never names semaglutide or tirzepatide on its public site, and its semaglutide ladder charges more per month the longer you commit.

Valhalla Vitality#284

Valhalla Vitality is a telehealth wellness platform offering compounded semaglutide and tirzepatide for weight loss, alongside peptide and hormone therapies.

Lttl#209

Lttl publishes monthly and longer compounded-injection offers plus a low-dose and oral menu; compare the actual charge and supply interval because annual equivalents and four-week labels describe different commitments.

BodyLogicMD#286

BodyLogicMD is a US telehealth and clinic network (operating since 2003) best known for bioidentical hormone replacement therapy, now offering medically supervised GLP-1 weight management alongside it.

Curex#287

Curex (Curex, Inc.) offers compounded semaglutide ($149/mo) and tirzepatide ($199/mo) in injectable and oral dissolving tablet formats.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Medro's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

← Back to the scorecard